Target intelligence / Profile preview

Voltage-gated calcium channel-Protein Kinase A signaling pathway (VGCC-PKA pathway)

Target
VGCC-PKA pathway
Molecular classification
Ion channel, Enzyme, Signaling pathway, Receptor
01

Overview

The Voltage-gated calcium channel-Protein Kinase A (VGCC-PKA) signaling pathway in glutamatergic terminals is a fundamental regulatory mechanism for excitatory neurotransmission in the central nervous system. This pathway involves the activation of Protein Kinase A (PKA) via the cAMP second messenger system, which subsequently phosphorylates presynaptic voltage-gated calcium channels, specifically the N-type (Cav2.2) and P/Q-type (Cav2.1) channels (UniProt O00555, Q00975). Phosphorylation increases the open-probability and conductance of these channels, leading to enhanced calcium influx during neuronal depolarization and a corresponding increase in the release of glutamate into the synaptic cleft (Journal of Neuroscience, 2004). This mechanism is a key driver of synaptic plasticity and long-term potentiation, but its dysregulation is heavily implicated in pathological states such as chronic neuropathic pain and epilepsy, where it contributes to neuronal hyper-excitability (Nature Reviews Drug Discovery, 2007). Therapeutic interventions often target this pathway to dampen excessive glutamatergic signaling; for example, gabapentinoids bind to the alpha2-delta subunit of VGCCs to reduce channel trafficking, while opioids activate Gi/o-coupled receptors to inhibit adenylyl cyclase, thereby reducing PKA activity and subsequent calcium-dependent glutamate release (StatPearls, 2023).

Other names
Glutamatergic terminals / Ca2+ channel–PKA pathwayPresynaptic PKA-VGCC signalingcAMP-PKA-Ca2+ axisPKA-mediated glutamate release pathway
02

Mechanism of action

Modulation of presynaptic calcium influx through PKA-mediated phosphorylation of calcium channels to regulate the exocytosis of glutamate-containing vesicles.

03

Biological functions

Neurotransmitter releaseSynaptic plasticitySignal transductionCalcium homeostasis
04

Disease associations

Chronic painEpilepsyAnxietyNeurodegenerative diseaseNeuropathic pain
05

Safety considerations

SedationDizzinessAtaxiaCognitive impairmentPotential for physical dependenceWithdrawal symptoms
06

Interacting drugs

Gabapentin

5 more in the full profile.

07

Biomarkers

Cerebrospinal fluid glutamate levelsBrain glutamate levels (via Magnetic Resonance Spectroscopy)Cyclic AMP (cAMP) concentrationsPhospho-specific VGCC antibodies

Beyond the preview

Go deeper on Voltage-gated calcium channel-Protein Kinase A signaling pathway (VGCC-PKA pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated calcium channel-Protein Kinase A signaling pathway (VGCC-PKA pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call